학술논문
Bevacizumab added to neoadjuvant chemotherapy for breast cancer
Document Type
Clinical report
Author
Bear, Harry D.; Gong, Tang; Rastogi, Priya; Geyer, Charles E. Jr.; Robidoux, Andre; Atkins, James N.; Baez-Diaz, Luis; Brufsky, Adam M.; Mehta, Rita S.; Fehrenbacher, Louis; Young, James A.; Senecal, Francis M.; Gaur, Rakesh; Mangolese, Richard G.; Adams, Paul T.; Gross, Howard M.; Constantino, Joseph P.; Swain, Sandra M; Manounas, Eleftherios P.; Wolmark, Norman
Source
The New England Journal of Medicine. Jan 26, 2012, Vol. 366 Issue 4, p310, 11 p.
Subject
Language
English
ISSN
0028-4793
Abstract
The study aims to evaluate whether the addition of bevacizumab added to neoadjuvant chemotherapy would increase the rates of pathological complete responses in women with breast cancer. The results indicated that the use of such therapy did increase the rate of pathological complete response.